Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

BTG’s pulmonary embolism device work faster and at lower doses in study

British pharmaceutical firm BTG said its EKOS combination therapy device for pulmonary embolism (PE) was effective using smaller drug dosages and shorter treatment periods than the current standard.

Read More »

AstraZeneca Offloads Heart Drugs to Recordati in $300 Million Deal to Pump Up R&D

AstraZeneca PLC sold the European commercial rights to its beta-blocker heart drug Seloken and the associated fixed-dose combination Logimax to Italy-based Recordati S.p.A. for $300 million.

Read More »

Trimbow is the first triple combination in a single inhaler for the treatment of COPD to receive positive opinion from the CHMP in Europe

Chiesi Group announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) issued a positive opinion recommending marketing authorization for the extrafine triple combination ICS/LABA/LAMA, under the brand name Trimbow, for the first time in a single inhaler for the treatment of Chronic Obstructive Pulmonary Disease.

Read More »

CHMP backs Novartis’ Zykadia for first-line use

Novartis’ push to win approval for Zykadia as an initial treatment for a type of lung cancer got a lift with a positive recommendation from the EMA’s CHMP.

Read More »

5 Biotechs Releasing Highly Anticipated Data

A look at five biotech companies in the cancer market and their upcoming releases at the 2017 American Society of Clinical Oncology (ASCO).

Read More »

Two NIH Sources Reveal President Trump is Considering New Cuts to Biomedical Research

All eyes will be on the White House Is President Donald Trump is expected to release his full budget proposal–which reportedly still contains deep cuts to the National Institutes of Health (NIH).

Read More »

Apple CEO Spotted Wearing a Prototype Glucose-Tracker on the Apple Watch

Apple continues to delve into the medtech world. Chief Executive Officer Tim Cook was seen wearing a new device that monitors his blood sugar levels and tracks how those levels respond to things such as diet and exercise.

Read More »

Novartis to Shed Another 500 Jobs, Add 350 High-Tech Jobs

Novartis AG is shaking up its operations by terminating approximately 500 production and development positions in Switzerland, but adding an additional 350 jobs to its growing biotech business, Matthias Leuenberger said in a posting on the company’s Swiss site.

Read More »

FDA Approves Keytruda for Bladder Cancer

Merck’s Keytruda (pembrolizumab) received FDA approval for two new indications for certain patients with locally advanced or metastatic urothelial carcinoma, including first-line treatment in patients ineligible for cisplatin-containing chemotherapy.

Read More »

Kieran Walsh Appointed President of Greater Than One Inc.

Greater Than One Inc. (GTO) announced the appointment of Kieran Walsh as President of its US operations. Walsh is responsible for leading the GTO staff and offices in New York and San Francisco, and for providing oversight on all US-based accounts.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

June 2019 Focus: Payer access, biotech/biopharma, DTC, rare diseases, and more!


Ad Right Bottom